You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
Glucose Sensor and Pump System Expected to Get U.S. Approval This Year
On November 13, 2000, it was announced that surgeons in Montpellier, France, implanted the world's first internal artificial pancreas in a person with diabetes.
"This is the first time that such a prototype has been implanted in a person," said Professor Eric Renard, who headed the operation that took place in October 2000.
According to French news wire reports, the patient who received the artificial pancreas was a type 1 and received the long-term implantable glucose sensor and pump system developed by MiniMed and licensed to Medical Research Group.
The pump, which is anticipated to reach the U.S. market sometime this year, has been approved in Europe. It is surgically placed under the skin and filled every few months by a physician. The insulin-delivery catheter is placed into the lining of the abdominal cavity, providing portal-vein insulin absorption.
In September 2000, Jeffrey Joseph, director of the Artificial Pancreas Center at Thomas Jefferson University in Philadelphia, told DIABETES HEALTH the MiniMed/MRG technology could be "the first fully implantable artificial pancreas."
The French researchers are saying their clinical trial will enable them to evaluate the life of the detector of blood-sugar levels.
"[We] anticipate the life-span of the device to be around two years," says Renard, adding that clinical tests will include implants being given to 50 patients-10 in the French city of Montpellier and 40 in the United States.
Under the current trial, the patient remains connected to a computer system so doctors can monitor the performance of the device.
Renard said he was confident that beneficiaries would quickly be fully autonomous, given the device had been successfully on a diabetic animal.
"This clinical trial is a crucial step in the progression to realizing an implantable artificial pancreas," said Alfred W. Mann, president and director-general of MRG.
Categories: Artificial Pancreas, CGMs, Diabetes, Diabetes, Insulin
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...